Novel CYP2E1 haplotype identified in a South African cohort

被引:1
|
作者
Heathfield, Laura J. [1 ]
Dalvie, Shareefa [1 ]
Kalideen, Kusha [1 ]
Dandara, Collet [1 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis, Div Human Genet, ZA-7925 Cape Town, South Africa
基金
新加坡国家研究基金会;
关键词
CYP2E1; haplotype; alcohol metabolism; molecular autopsy; South Africa; LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISMS; ACETALDEHYDE; POPULATION; ETHANOL; PHARMACOGENETICS; ASSOCIATION; PATTERNS; SHESIS;
D O I
10.1590/sajs.2014/20130324
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alcohol abuse accounts for approximately 2.5 million deaths annually and is the third highest risk factor for disease and disability. Alcohol is metabolised by polymorphic enzymes and the status of an individual with respect to alcohol metabolising enzymes may have forensic relevance in post-mortems. Baseline frequencies of gene variants involved in alcohol metabolism need to be established to aid the identification of suitable population-specific polymorphisms to genotype during molecular autopsies. The principal alcohol metabolising enzymes include alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) and cytochrome P450 2E1 (CYP2E1). Six single nucleotide polymorphisms (SNPs) - rs1229984G>A and rs2066702C>T in ADH1B, rs671G>A in ALDH2, and rs3813867G>C, rs2031920C>T and rs6413432T>A in CYP2E1 - were genotyped in 150 individuals from four South African populations: Xhosa, Zulu, South African white and South African coloured. Allele frequencies for each SNP in the four population groups were 0-10% for rs1229984A, 2-12% for rs2066702T, 0-2% for rs671A, 1-4% for rs3813867C, 0-1% for rs2031920T and 3-15% for rs6413432A. Haplotype analysis revealed a novel combination of three SNPs in CYP2E1 whose effects on alcohol metabolism need further investigation. Establishment of baseline frequencies adds to our knowledge of genetic variation in alcohol metabolising enzymes and additional research is required to determine the functional significance of this novel CYP2E1 haplotype.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 50 条
  • [1] CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 Allele Frequencies in Iranian Populations
    Shahriary, Ghazaleh Mohammadzadeh
    Galehdari, Hamid
    Jalali, Amir
    Zanganeh, Fatemeh
    Alavi, Seyed Mohammad Reza
    Aghanoori, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6505 - 6510
  • [2] Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor
    Han, Zixinying
    Liu, Chenxu
    Li, Mingrui
    Deng, Mengyan
    Ding, Ying
    Li, Yunchao
    Huo, Meidan
    Xu, Haiwei
    Qiao, Hailing
    Gao, Na
    BIOCHEMICAL PHARMACOLOGY, 2024, 229
  • [3] Effect of the South African traditional meat, biltong, on cancer-associated enzymes CYP2E1 and CYP1A2
    Walubo, A
    Coetsee, C
    Badenhorst, AM
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2004, 94 (11): : 903 - 905
  • [4] GENETIC POLYMORPHISM IN CYP2E1: POPULATION DISTRIBUTION OF CYP2E1 ACTIVITY
    Neafsey, Pat
    Ginsberg, Gary
    Hattis, Dale
    Johns, Douglas O.
    Guyton, Kathryn Z.
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 362 - 388
  • [5] Novel CYP2E1 dependent farnesol ω-hydroxylation
    DeBarber, AE
    Bleyle, LA
    Roullet, JBO
    Koop, DR
    FASEB JOURNAL, 2003, 17 (05): : A1318 - A1318
  • [6] MECHANISM OF OXIDATION BY MITOCHONDRIAL CYP2E1 DIFFERS FROM MICROSOMAL CYP2E1
    Hartman, Jessica H.
    Martin, H. Cass
    Miller, Grover P.
    DRUG METABOLISM REVIEWS, 2015, 47 : 71 - 71
  • [7] A haplotype analysis of CYP2E1 polymorphisms in relation to alcoholic phenotypes in mexican americans
    Yang, Min
    Tsuang, John
    Wan, Yu-Jui Yvonne
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (12) : 1991 - 2000
  • [8] Detection and characterization of novel polymorphisms in the CYP2E1 gene
    Fairbrother, KS
    Grove, J
    de Waziers, I
    Steimel, DT
    Day, CP
    Crespi, CL
    Daly, AK
    PHARMACOGENETICS, 1998, 8 (06): : 543 - 552
  • [9] A Novel Role of CYP2E1 in Human Megakaryocyte Development
    Tang, Yan
    Zhang, Guojuan
    Baird, Maureen
    Racke, Frederick
    Zhao, Weiqiang
    IN VIVO, 2014, 28 (06): : 1077 - 1084
  • [10] INCREASED STABILITY OF MITOCHONDRIAL CYP2E1 AGAINST DEGRADATION COMPARED TO MICROSOMAL CYP2E1
    Hartman, Jessica H.
    Caro, Andres A.
    Ronis, Martin J.
    Miller, Grover P.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S54 - S54